KCNJ4

Chr 22

potassium inwardly rectifying channel subfamily J member 4

Also known as: HIR, HIRK2, HRK1, IRK-3, IRK3, Kir2.3

The protein is an inwardly rectifying potassium channel that preferentially allows potassium flow into cells rather than out, playing a key role in neuronal and muscle cell excitability. This gene is highly constrained against loss-of-function variants (pLI 0.96, LOEUF 0.29), suggesting that mutations likely cause severe developmental phenotypes, though specific associated diseases have not yet been definitively established in the literature. The high constraint scores indicate that pathogenic variants in this gene would be expected to cause significant clinical consequences.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.29
Clinical SummaryKCNJ4
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.96). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
22 unique Pathogenic / Likely Pathogenic· 36 VUS of 63 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint
0.29LOEUF
pLI 0.965
Z-score 2.99
OE 0.00 (0.000.29)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
3.97Z-score
OE missense 0.39 (0.330.45)
128 obs / 331.3 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios
LoF OE0.00 (0.000.29)
00.351.4
Missense OE0.39 (0.330.45)
00.61.4
Synonymous OE0.97
01.21.6
LoF obs/exp: 0 / 10.4Missense obs/exp: 128 / 331.3Syn Z: 0.31
DN
0.5378th %ile
GOF
0.78top 25%
LOF
0.55top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFLOEUF 0.29
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

63 submitted variants in ClinVar

Classification Summary

Pathogenic19
Likely Pathogenic3
VUS36
Likely Benign1
Benign2
Conflicting1
19
Pathogenic
3
Likely Pathogenic
36
VUS
1
Likely Benign
2
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
19
0
19
Likely Pathogenic
0
0
3
0
3
VUS
0
34
2
0
36
Likely Benign
0
0
0
1
1
Benign
0
0
1
1
2
Conflicting
1
Total03425262

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

KCNJ4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →